Role of individualization of hepatitis C virus (HCV) therapy duration in HIV/HCV-coinfected individuals. [electronic resource]
Producer: 20061109Description: 248-54 p. digitalISSN:- 1464-2662
- Adult
- Antiretroviral Therapy, Highly Active
- Antiviral Agents -- administration & dosage
- Blood Cell Count
- CD4 Lymphocyte Count
- Drug Administration Schedule
- Drug Carriers
- Drug Therapy, Combination
- Female
- Genotype
- HIV Infections -- blood
- Hepacivirus -- isolation & purification
- Hepatitis C -- blood
- Humans
- Interferon alpha-2
- Interferon-alpha -- administration & dosage
- Male
- Mental Disorders -- chemically induced
- Polyethylene Glycols -- administration & dosage
- Prospective Studies
- RNA, Viral -- analysis
- Recombinant Proteins
- Ribavirin -- administration & dosage
- Treatment Outcome
- Viral Load
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.